speb/financial-data huggingface dataset:
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1356242000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Amortization: 1340000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 1340000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 71285000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 104054830.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 1.75
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 29355000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 331781000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -790546000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 2251000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 104055000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 93521000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 478495000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -31216000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 44307000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 49214000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -201714000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -85361000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -22195000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 64336000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 216626000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -28308000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 69817000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 104055000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 4137133000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 851182000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 724700000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 3159184000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 2803058000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 135000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 444723000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 444858000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 2646000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1255197000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 11912000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 108459000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 109799000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 109800000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 108460000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 113502709.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 1.61
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 182214000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 94000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — EBIT: 321961000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 431761000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 77000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 99249000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 883146000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 583057000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -447667000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -12911000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 1281000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 64435000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 22400000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1071026000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3728441000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 915802000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 52739000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 52739000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 8360000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 8360000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -51311000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 8360000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 1114889000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 4751270000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1156208000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 71285000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 851182000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 155819000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 2116000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 169414000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 171530000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 160000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2286026000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 851182000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 520616000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -556000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Income: 182214000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 182214000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 182214000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 182214000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 182214000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 269222000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 182214000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -68534000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -374022000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 114491000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 3695000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -68534000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2863953000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -790546000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 110796000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 4114733000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 9148000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 187271000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 160000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 50963000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 418850000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 173475616.98
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 342879000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 320857000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 4074986000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 104054830.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 71000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 851182000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 22400000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 1685000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 42988000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 1000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 2299000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 9002000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 134135000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 230115000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 2360000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 384974000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 786759000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 9001000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 20760000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 119217000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 269222000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 0.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -790546000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 332552000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 3159184000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 109799000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 3750000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 3750000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Research And Development: 25090000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 17012000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 1735380000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 53086000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 117521000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 104054830.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 4137133000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 4114733000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 4172616.98
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 87008000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.32
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 60000.00
BHAGCHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -47640000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 5760440000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 4306547000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 616388000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 4137133000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 3754129000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1623307000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2957381000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 368110000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 24155000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 2646000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 12911000.00
BHAGCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 12911000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 197595000.00
BHAGCHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1547861000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 713138000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1580711000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 72493000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 2319000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 124435000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 585175000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1651813000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 124435000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 6270063000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 1202581000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4538539000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 203000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 596905000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 597108000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1564013000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 18843000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 25016000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 3403640000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1195199000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 7144403000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 72493000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 2116000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 277435000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 279551000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 270000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 289165000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 3403640000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 6245047000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 212052000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 124434980.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 110433000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 10206000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 6145628000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 25016000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 293886000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 1000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2201059000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1066638000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 719417000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 124434980.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 6270063000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 6245047000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 383000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 8333574000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 6547498000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 876659000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 6270063000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 2063511000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 3795035000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 499498000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 6279000.00
BHAGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2974526000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 712120000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 364370000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 4403111000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1226222000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 931780000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 931780000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1738607000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1738607000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -998756000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -998756000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 4739728000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 4739728000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Amortization: 3509000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 3509000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 59176000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 59176000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 121810687.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 110525000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 1.14
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.08
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 99249000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 550792000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 550792000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -2522831000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 44655000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 44655000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 129669000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 129669000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 282253000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 282253000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 282314000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 282314000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -12449000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 265283000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 265283000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 16970000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 16970000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -182222000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -291290000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 53146000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 282273000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -667753000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -805846000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 183004000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 129669000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 129669000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 6822219000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6822219000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 2557918000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 3061217000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 3061217000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 3458621000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 837034000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 3748783000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 3748783000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 12326000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 12326000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 544020000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 544020000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 556346000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 556346000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 20098000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 20098000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1952553000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1952553000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 28985000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 28985000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 138639000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 138639000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 138640000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 35952000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 135131000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 35952000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 121810687.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 110525000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 1.14
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.08
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 138573000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -8842000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 99000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 99000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — EBIT: 303913000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 37986000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — EBITDA: 442553000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 73938000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 282253000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 2716632000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 513423000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 513423000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -3050820000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -52890000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 350000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 66061000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 30777000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 30777000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1738607000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1738607000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 6490684000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6490684000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 944490000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 389188000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 51417000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 15524000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 51417000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 15524000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Interest Income: 35617000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 35617000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -48748000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 35581000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 1297109000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1297109000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 7666704000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7666704000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -2005639000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 59176000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 59176000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 2557918000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 155819000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 155819000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 32329000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 32329000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 300465000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 300465000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 332794000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 332794000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 2461000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 2461000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2473276000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2473276000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 2557918000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 562232000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 562232000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -2850000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Income: 138573000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income: -8842000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 138573000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -8842000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 138573000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -8842000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 138573000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -8842000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 138573000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -8842000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 252496000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 138573000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -8842000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -34951000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -15524000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 445949000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 230275000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 131050000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -34951000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -15524000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 1000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 5491928000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 5491928000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -2487169000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 99225000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 6791442000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6791442000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 7624000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 7624000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 213896000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 213896000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2461000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2461000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 45477000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 45477000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 389663000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 73938000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 101550000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -8842000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -527989000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Operating Income: 232370000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 24818000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 4403111000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1226222000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 129669080.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 129669080.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 410874000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 410874000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 30951000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 30951000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 6692550000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 6692550000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 30777000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 30777000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 1997000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 1997000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 14275000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 183091000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 183091000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 1145000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 13168000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 11739000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 218496000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 415245000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 415245000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 249580000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 249580000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 2443000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 2443000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 61000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 61000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Payables: 1347124000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1347124000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 11687000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 28985000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 28985000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 411872000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 411872000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 252496000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 22462000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -2522831000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 505684000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 505684000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 3458621000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 837034000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 138639000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 35952000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 3876000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 3876000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Research And Development: 30201000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 15522000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 15522000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1862548000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1862548000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 35662000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 57927000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 123988000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 129669080.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 129669080.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 6822219000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6822219000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 6791442000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6791442000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 15867000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 113923000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 31304000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 916000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 916000.00
BHAGCHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -72163000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 9331547000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 9331547000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 7122684000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 7122684000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 889140000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 889140000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 6822219000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6822219000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 4170741000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1201404000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 2509328000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2509328000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 5582764000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5582764000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 556775000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 556775000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 19151000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 20098000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 20098000.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 52890000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
BHAGCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 52890000.00
BHAGCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 276005000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 276005000.00
BHAGCHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1796230000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1796230000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 363995000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1237778000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 124346875.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.32
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 822535000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 38660000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 38660000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 124346875.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.32
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 57624000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 96284000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 415243000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 32610000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 32610000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -32610000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -32610000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 96284000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 39791000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 51248000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1237778000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 6377000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 211381000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 25014000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 822535000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 38660000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -14777000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1186530000.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 376420000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1400972000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1045710000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2119398000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 64643000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 131054762.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.42
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 43612000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 129669000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 127336000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 143571000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 129669000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6896858000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 3773636000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 913514000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 3919475000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 12393000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 647795000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 660188000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2072873000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 28394000.00